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Factors Influencing Functional Survival of Microencapsulated Islet Grafts
Paul de Vos, Bart J. de Haan, Aalzen de Haan, Jacoba van Zanten, and Marijke M. Faas
Transplantation Biology and Immunoendocrinology, Department of Pathology and Laboratory Medicine,
Section of Medical Biology, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
Graft function of encapsulated islets is restricted in spite of the fact that inflammatory responses against
capsules are limited to a portion less than 10%. It has been shown that dysfunction is accompanied by a
gradual decrease in the glucose-induced insulin response (GIIR), a hyperproliferation of islet cells, and
gradual necrosis. Also, limited survival is associated with the presence of macrophages in the overgrowth.
In the present study, we investigate whether macrophages are the inducers of dysfunction of encapsulated
grafts. Four weeks after successful transplantation of microencapsulated rat allografts we determined the
GIIR, the rate of islet cell replication, and islet cell death. Also, we quantified the number of macrophages
on the overgrown capsules. This assessment was applied to set up an in vitro coculture system of macro-
phages and encapsulated islets. We retrieved 93 ± 6.2% of the capsules of which 9.2 ± 0.3% was overgrown.
The GIIR of the retrieved nonovergrown islets was reduced when compared with freshly encapsulated islets.
The replication rate of the retrieved islet cells was eightfold higher than in the normal pancreas. Apoptosis
was rarely observed but 37 ± 4% of the total islet surface was composed of necrosis. We found a mean of 1542
± 217 macrophages per capsule. Coculture of 1500 NR8383 macrophages per encapsulated islets induced a
substantial reduction in GIIR but a decrease instead of increase in replication. Necrosis was restricted to 13 ±
1.3% of the islet cells and was not increased by the presence of macrophages. Our observations indicate that
we should focus on reduction of macrophage activation and on improving the nutrition of encapsulated islets
to prevent islet cell death.
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INTRODUCTION than fibrotic overgrowth with subsequent necrosis of the
islets contribute to failure of the encapsulated islet grafts.
These are islet-related factors such as limited life spanEncapsulation in alginate–poly-L-lysine (PLL)-based
microcapsules (22) is a commonly applied procedure for of islets (1,15) but also indirect effects of the tissue re-
sponse against the encapsulated islets, as will be dis-immunoprotection of pancreatic islets. During recent
years, important advances have been made with this cussed in the next sections.
The cellular overgrowth on the small portion of 2–technology. The introduction of pure and new types of
alginates (7,18,28) and methods for testing the integrity 10% of the capsules is mainly composed of ED-1 and
ED-2 macrophages (8). In a previous study we sug-of the capsules has been associated with a substantial
reduction of fibrotic overgrowth from all capsules to a gested that these macrophages contribute to cessation of
the graft not only by overgrowth and subsequent necro-portion of 2–10% of the capsules (7,13). This improve-
ment of biocompatibility is beneficial for functional sis of the islets but also by secretion of cytokines with
potential deleterious effects on the islets in 90–98% ofgraft survival, because normoglycemia was observed
during 2 to 6 months in streptozotocin diabetic recipients nonovergrown encapsulated islets.
The present study was undertaken to study the mech-of microencapsulated islet allo- and isografts (7,23,27).
Although this illustrated the principle applicability of anism and quantify the effect of macrophages in the 2–
10% overgrowth on the nonovergrown encapsulatedthe alginate encapsulation technique, a fundamental bar-
rier needed to be overcome because graft survival varied islets. To this end, we studied transplanted microencap-
sulated islets at 4 weeks after implantation. At the timeconsiderably in our studies from 2 to 6 months and was
never permanent (5,7,11). Obviously, processes other of peritoneal lavage, encapsulated islets were tested for
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their ex vivo insulin response to glucose, the rate of islet Animals and Induction of Diabetes
cell proliferation, and the percentage of nonviable tissue Male inbred Albino Oxford (AO/G) and Lewis rats
in the islets because we have observed disturbed patterns were obtained from Harlan (Harlan CPB, Zeist, The
for these parameters in previous studies (13). To investi- Netherlands) or the Central Animal Laboratory of Gron-
gate whether these assessments are correlated with the ingen. NHI guidelines for the care and use of laboratory
presence of macrophages in the immediate vicinity of animals were observed.
encapsulated islets, we applied a coculture system of en- Male inbred Lewis rats weighing 300–350 g served
capsulated islets with macrophages to mimic the in vivo as donors. Male inbred AO/G rats weighing 290–320 g
situation. were used as recipients of encapsulated islet grafts. Dia-
betes was induced by injection of 75–90 mg/kg of strep-
tozotocin (Zanosar, Upjohn Co., Kalamazoo, MI) via theMATERIALS AND METHODS
tail vein. Glucose concentration in blood was deter-Design of the Study
mined with glucose test tapes (Reflolux, Boehringer
Alginate–PLL microcapsules were implanted in the Mannheim, FRG). Only animals with severe weight
peritoneal cavity (i.e., the usual transplantation site for loss, polyuria, polydipsia, and blood glucose levels ex-
an encapsulated islet graft) of AO rats. Only highly puri- ceeding 20 mmol/L over a period of at least 4 weeks
fied alginates were applied to exclude that contaminat- were used as recipients. To exclude β-cell regeneration,
ing components were the cause of an inflammatory re- we always took a biopsy from the pancreas at the time
sponse. The capsules were inspected before and after of peritoneal lavage.
implantation to confirm that the majority of the capsules
Islet Isolationwere intact. The capsules were retrieved at 4 weeks
postimplant by peritoneal lavage. Islets were isolated as previously described (32).
Briefly, under ether anesthesia, the abdomen was openedAt the time of peritoneal lavage the encapsulated is-
lets were divided in two portions. The first portion was and the common bile duct was cannulated under non-
sterile conditions. The donor pancreas was distendedapplied to determine the ex vivo insulin response to glu-
cose, the rate of islet cell proliferation, and the percent- with 10 ml sterile Krebs-Ringer-HEPES (KRH) supple-
mented with 25 mmol/L HEPES buffer and containingage of nonviable tissue in the islets. The second portion
was used for determination of the percentage of over- 10% bovine serum albumin (BSA). Subsequently, the
pancreas was excised and brought into a laminar flowgrowth of the encapsulated graft and for quantification
of the number of macrophages in the capsular overgrowth. cabinet. All further procedures were performed under
sterile conditions.The total volume of the graft recovered by peritoneal
lavage was related to the initial volume of the transplant. The pancreas was chopped, digested using a two-
stage incubation of 20 min at 37°C with successivelyThe number of recovered capsules with cellular over-
growth was assessed by microscopy of histological sec- 1.0 and 0.7 mg/ml collagenase (Sigma type XI, Sigma,
St. Louis, MO). Islets were separated from exocrine tis-tions. This fraction was expressed as the percentage of
the total number of recovered capsules. sue by centrifugation over a discontinuous dextran gra-
dient (31) and further purified by handpicking.The number of ED-1 and ED-2 positive macrophages
in the overgrown capsules was quantified by microscopy The total islet volume was determined by measuring
the diameters (30) of islets in a 4% aliquot of the isletof histological sections of the graft. The counted number
of macrophages was related to the percentage of over- suspension. The diameters were measured with a dissec-
tion microscope with a fluorescent illuminator (Bauschgrown capsules in the graft. The number of macrophages
was expressed as the quantity of macrophages per cap- and Lomb BVB-125, and 31-33-66) equipped with an
ocular micrometer with an accuracy of 25 µm. The totalsule. These assessments were applied to culture rat mac-
rophages (NR8383) with 100 encapsulated Lewis rat volume was calculated, assuming the islets to be perfect
spheres. In each experiment we used four to five donorsislets. After 48 h of coculture with macrophages, encap-
sulated islets were harvested and tested for their ability from which we isolated a total of 3500–4200 islets,
which corresponds to 10–15 µl of islet tissue.to respond to a glucose load with an insulin response
and processed for histological determination of the num- Islets were cultured before encapsulation to reduce
contamination of the grafts with exocrine tissue, ducts,ber of replicating islet cells, and the percentage of non-
viable tissue. Cocultures of LPS-activated rat macro- or damaged cells. They were cultured in nontreated petri
dishes (Greiner, Alphen a/d Rijn, The Netherlands) inphages with encapsulated islets were applied to assess
the protective effect of capsules for macrophage-derived portions of 100 islets per 25 cm2 for 19–44 h in RPMI-
1640 [containing 10% fetal calf serum (FCS, Gibco,cytokines. Cultures of encapsulated Lewis rat islets served
as control. Breda, The Netherlands), 8.3 mmol/L glucose, 10 mmol/
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L HEPES, and 1% penicillin/streptomycin] at 37°C in sules were immediately fixed after lavage to avoid inap-
propriate activation of the adherent cells (vide infra).humidified air containing 5% CO2. After this culture pe-
riod the total islet volume was assessed again. Graft From this tube, the microcapsules were brought into a
measure cylinder to assess the retrieved volumes withendocrine volume was at least 10 µl, which is approxi-
mately equal to the endocrine volume of the normal rat an accuracy of 0.05 ml as described above. Also, we
confirmed that the diameter of the capsules had notpancreas (31).
changed during implantation and subsequent fixation be-
Microencapsulation cause a change in diameter of the capsules could inter-
fere with adequate measurement of the retrieved graftAfter culture, islets were washed three to five times
with RPMI containing 10% FCS and were subsequently volume (13). Subsequently, the microcapsules adhering
to the surface of abdominal organs were excised andsuspended in sterile filtered (0.2 µm filtration) 3–3.3%
purified alginate solution. The alginate solution was processed for histology.
converted into droplets using an air-driven droplet gen-
Cell Cultures and Co-incubationerator as previously described (6,33). PLL–alginate en-
capsulation was performed as described elsewhere (17). Before starting the in vitro experiments we selected
an appropriate macrophage source for mimicking the inBriefly, the alginate droplets were transformed to algi-
nate beads by gelling in a 100 mM CaCl2 (10 mM vivo situation. To this end, we first tested the feasibility
of using residential macrophages either from overgrownHEPES, 2 mM KCl) solution for at least 5 min. Subse-
quently, the Ca–alginate beads were suspended for 1 capsules, from peripheral blood, or (proteose–peptone-
elicited) peritoneal macrophages (2). This was done bymin in KRH containing 2.5 mmol/L CaCl2. A PLL mem-
brane was formed by suspending the alginate beads in comparing the number of iNOS-positive macrophages
obtained from the in vitro system with those collected0.1% PLL solution for 10 min (PLL-HCl, MW 22,000,
Sigma). Nonbound PLL was removed by three succes- in vivo on capsules directly fixed after being flushed
from the peritoneal cavity. Unfortunately, none of thesive washings during 3 min with Ca2+-free KRH contain-
ing 135 mM NaCl. The outer alginate layer was subse- sources were adequate for application in the in vitro sys-
tem because isolation and processing of the macro-quently applied by 5-min incubation in 10 times diluted
alginate solution. The capsules had a diameter of 600– phages for in vitro application were associated with
strong and inappropriate activation of the cells as evi-700 µm as measured with a dissection microscope
(Bausch and Lomb BVB125) equipped with an ocular denced by iNOS expression in 80–95% of the macro-
phages, while it was always less than 50% of the macro-micrometer with an accuracy of 10 µm. The total graft
volume was determined in a measure cylinder, with an phages directly fixed after flushing from the peritoneal
cavity. Another reason prohibiting the use of the above-accuracy of 0.05 ml.
mentioned macrophages as a cell source was that it was
Transplantation and Retrieval not applicable for long-term cultures because a substan-
of Microencapsulated Islets tial number of the macrophages died within hours after
starting the incubations at 37°C. Therefore, in our subse-Under halothane anesthesia, the microencapsulated
islets were injected into the peritoneal cavity with a 16- quent approach we concentrated on finding an appro-
priate macrophage cell line instead of resident macro-gauge cannula via a small incision (3 mm) in the linea
alba. The abdomen was closed with a two-layer suture. phages.
In total we have tested the adequacy of eight differentThe implanted volumes varied between 2.0 and 2.5 ml.
Blood glucose was determined at regular time intervals cell lines. In these tests we not only studied and com-
pared iNOS expression but also the ability of the cellin blood sampled from the tail vein. The glucose con-
centration was determined with glucose test tapes (Re- line to secrete IL-1β and TNF-α in a dose-dependent
fashion upon activation with lipopolysaccharide (LPS,flolux). Recipients with a blood glucose level less than
8.4 mmol/L were considered normoglycemic. E. coli, Sigma). Only the Sprague-Dawley macrophage
cell line NR8383 (ATCC, Manassas, VA) (19) provedMicrocapsules were retrieved at 4 weeks after trans-
plantation. Microcapsules were mostly freely floating to be adequate for application in our test system because
processing for culture was not associated with increasedand nonadherent, but occasionally we found some cap-
sules adhering to the surface of intra-abdominal organs. expression of iNOS and it was one of the few cell lines
that was found to secrete IL-1β and TNF-α in a dose-First, nonadherent microcapsules were retrieved by peri-
toneal lavage, performed by infusing 20 ml KRH dependent fashion upon activation with LPS.
Before application in the experiments, the NR8383through a 3-cm midline incision into the peritoneal cav-
ity and subsequent flushing with additional KRH for two macrophage cell line was cultured in 60-ml culture
flasks containing RPMI-1640 with 10% fetal calf serum,or three times above a 50-ml centrifuge tube. The cap-
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8.3 mmol/L glucose, 10 mmol/L HEPES, and 1% peni- of samples of 25 islets each. Consequently, the insulin
secretory responses of islets from in vitro culture experi-cillin/streptomycin. The cultures were kept at 37°C in
humidified air containing 5% CO2. ments were expressed as nanogram of insulin ml−1 10
islets−1 45 min−1.In the co-incubation experiment four separate sam-
ples of 100 encapsulated islets were incubated with an
Histology and Assessment of Capsular Overgrowthappropriate quantity of macrophages (see Results sec-
tion) in 12-well plates and subsequently cultured for 48 Nonadherent capsules recovered by peritoneal lavage
were always divided in three portions. One portion wash in RPMI-1640 with 10% fetal calf serum, 8.3 mmol/
L glucose, 10 mmol/L HEPES, and 1% penicillin/strep- fixed in precooled 2% paraformaldehyde, buffered with
0.05 M phosphate, and processed for GMA embeddingtomycin at 37°C in humidified air containing 5% CO2.
As a negative control on macrophage activation we used (4), the second portion was frozen in precooled iso-propaan
(5), and the third portion was fixed in Bouin’s solutionthe results of cultures of encapsulated islets alone with-
out macrophages. NR8383 macrophages activated with for paraffin processing (16).
GMA sections were prepared at 2 µm and used for1 µg/ml LPS served as positive controls. This amount
of LPS maximally stimulates cytokine production (8). the following assessments. GMA sections stained with
Romanovsky-Giemsa were used to assess the degree ofIslets were harvested and processed for measurement of
insulin secretion during glucose challenge or processed capsular overgrowth, which was quantified by express-
ing the number of recovered capsules with overgrowthfor glycol methacrylate (GMA) embedding as described
below. as the percentage of the total number of recovered cap-
sules for each individual animal. The same sections were
BrdU Labeling of Islets used for assessing the percentage of necrotic tissue in
the islets as previously described (13). Briefly, necrosisTo label replicating cells in vivo, a bromo-2-deoxy-
uridine (BrdU) tablet (Boehringer Mannheim) was im- in the retrieved islets was assessed by identifying cells
or groups of cells in the islets with the morphologicalplanted subcutaneously via a small incision in the skin
of the neck at exactly 6 h before peritoneal lavage. characteristics of necrosis. To this end, 40–100 recov-
ered islets were microscopically examined to identifyFor BrdU labeling of encapsulated islet cells in vitro,
islets were incubated for 6 h in culture medium contain- cells with a swollen appearance, cells with a loss of
plasma integrity, and zones in the islets composed ofing 10 µM BrdU. BrdU labeling was always performed
in culture medium containing 15 mM glucose, a concen- cell debris. Subsequently, the necrosis in the islets was
quantified by expressing the mean surface area of thetration that stimulates islet cell replication (25).
islets composed of necrotic tissue as the percentage of
Insulin Secretion During Glucose Challenge the total surface area in each individual islet. Also,
GMA sections of nonadherent capsules were processedDirectly after peritoneal lavage, microencapsulated
islets were tested ex vivo in four separate samples of for identification of BrdU-positive cells in the β-cell
fraction of the islets. To this end, we applied a double25 islets for their glucose-induced insulin response. To
minimize the variability of the mean insulin responses, staining protocol for the non-β-cell hormones and BrdU
as previously described (13). We choose to stain thewe meticulously selected islets with diameters between
150 and 200 µm. The encapsulated islets were preincu- non-β-cells in the islets in combination with BrdU in-
stead of β-cells and BrdU because in the grafts we oftenbated for 45 min in 2 ml Krebs-Ringer-bicarbonate
(KRB), gassed with 95% O2 and 5% CO2, containing found degranulated islet cells that would be missed as
β-cells when the latter technique was applied. The ade-0.25% BSA and 2.75 mM glucose. The ex vivo insulin
secretion was then assessed by three consecutive incuba- quacy of this approach has been shown in a previous
study (13).tions of (i) 45 min in 2.75 mM glucose in KRB, (ii) 45
min in 16.5 mM glucose in KRB, and (iii) 45 min in The sections were incubated with a cocktail of the
following antibodies: rabbit anti-glucagon (DAKO, Santa2.75 mM glucose in KRB. At the end of each incuba-
tion, the incubation media were removed and frozen for Barbara, CA), rabbit anti-human somatostatin (DAKO),
and rabbit anti-human pancreatic polypeptide (DAKO).insulin determination by a radioimmunoassay for insulin
(Linco, St. Charles, MO) using rat insulin as a standard. After several washings, sections were incubated with a
goat anti-rabbit, alkaline phosphatase conjugated secondGroups of 25 freshly isolated and encapsulated islets
served as control. The insulin secretory responses were step reagent. Phosphatase activity was demonstrated by
applying Naphtol As-MX phosphate disodium salt andexpressed as picogram of insulin L−1 25 islets−1 45 min−1.
Islets obtained from culture experiments were tested Fast Blue BB salt. Next, the sections were pretreated
with HCl for DNA denaturation and incubated with aaccording to the same procedure with one exception. We
applied four separate samples of 10 islets each instead mouse monoclonal antibody against BrdU. After several
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washing steps the sections were incubated with rabbit ments were fixed in precooled 2% paraformaldehyde,
buffered with 0.05 M phosphate, and processed foranti-mouse, peroxidase-conjugated second step reagent.
Peroxidase activity was demonstrated by applying 3- GMA embedding. Sections were prepared at 5 µm and
processed for immunocytochemical staining of BrdU-amino-9-ethylcarbazole (AEC) containing hydrogen per-
oxide. Finally, the sections were incubated, in sequence, positive islet cells with staining for non-β-cell hor-
mones. Quantification of islet cell replication was per-in celestin blue and hematoxylin for staining the cell
nuclei. All cells in the sections were counted by an in- formed in the same way as specified above for β-cell
replication. At least 500 islet cells were counted per ex-vestigator. At least 600 cells were counted per graft. The
number of BrdU-positive β-cells was expressed as the periment.
Pancreas biopsies were fixed in Bouin’s solution forpercentage of the total number of counted β-cells.
The second portion of the recovered capsules was paraffin processing, sectioned at 5 µm, and processed
for immunocytochemistry as described above for deter-sectioned at 5 µm and processed for immunohistochemi-
cal staining as previously described (5). The monoclonal mination of the number of BrdU-positive cells or for
identification of apoptotic β-cells.antibodies used were: a combination of ED-1 and ED-2
against monocytes and macrophages and subset of mac-
Statistical Analysisrophages (14), HIS-40 against IgM bearing B-lym-
phocytes (3), HIS-48 against neutrophilic granulocytes Results are expressed as mean ± SEM. Statistical
comparisons were made with the Mann-Whitney U test.(29), R73 against CD3+ bearing T-lymphocytes (20), and
ASIALO-GM1 directed to natural killer (NK) cells (26). A value of p < 0.05 was considered statistically signifi-
cant.After several washing steps the sections were incubated
with appropriate horseradish peroxidase-conjugated sec-
RESULTSond step reagents. Peroxidase activity was demonstrated
by applying 3,3′-diaminobenzidine tetra HCl containing Composition and Degree of Cellular Overgrowth
of the Graftshydrogen peroxide. In control sections we used PBS in-
stead of the first stage monoclonal antibody. This second All five diabetic AO recipients of encapsulated Lewis
portion was not only used to study the composition of rat islets became normoglycemic within 5 days after im-
the overgrowth but also to assess the number of ED-1- plantation and remained normoglycemic for the study
and ED-2-positive macrophages in the capsular over- period of 4 weeks. Encapsulated grafts were retrieved
growth. To this end, we counted the macrophages in by peritoneal lavage at 4 weeks after implantation.
each graft on at least 100 sectioned overgrown capsules. The majority of the capsules of 93 ± 6.2% were
Then we calculated for each graft the total number of freely floating in the abdominal cavity without adhesion
cells on the overgrown capsules, considering the cap- to the abdominal organs (Fig. 1). Occasionally, we
sules to be perfect spheres. The cell number was ex- found a portion of the capsules adhering to the omentum
pressed as a mean number of cells per recovered cap- or liver capsule. All capsules adhering to the abdominal
sules for each individual animal.
The third portion of nonadherent capsules was sec-
tioned at 5 µm and stained for non-β-cell hormones as
described above. Subsequently, apoptotic cells were im-
munostained by applying a modified terminal digoxi-
nucleotidyl transferase (TDT) method (Apoptac, Oncor,
Gaithersburg, MD). The apoptotic cells were identified
by microscopy. A cell was classified as apoptotic when
the nucleus was immunostained and had the characteris-
tic morphology of an apoptotic cell (i.e., a β-cell con-
taining a condensed or fragmented nucleus). Islets in se-
rial slices treated with DNAse I (5 mg/ml, 20 s, 37°C)
and lymph nodes in the pancreas served as positive con-
trols. In addition, we quantified apoptosis by assessing
the number of apoptotic bodies in GMA-embedded, Ro-
manovsky-Giemsa-stained slices of encapsulated islets.
Processing for GMA embedding and Romanovsky- Figure 1. Free-floating alginate–PLL encapsulated islets inGiemsa staining was also applied to samples of adherent the peritoneal cavity of cured AO rats 1 month after implanta-
capsules recovered by excision. tion. The arrows indicate free-floating capsules in between the
abdominal organs. G indicates a gut.BrdU-labeled islets obtained from in vitro experi-
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organs were found to be overgrown by fibrotic tissue The normal percentage of β-cell replication was deter-
mined in the pancreas of age-matched nondiabetic con-and occasionally by some macrophages. Of the 93 ±
6.2% capsules retrieved by peritoneal lavage, the mean trols. As shown in Figure 3, β-cell replication in nor-
moglycemic recipients was eightfold higher in encapsulatedpercentage of capsules with overgrowth was 9.2 ± 0.3%
and varied between 1% and 14%. The composition of islets than in islets in the normal pancreas.
With the exception of a few encapsulated isletsthe overgrowth on the 9.2 ± 0.3% of free-floating cap-
sules was different from that on capsules adhering to smaller than 100 µm, all encapsulated islets contained
necrotic cells. This necrosis varied from single-cell ne-the abdominal organs. The free-floating capsules were
surrounded by some fibrotic tissue but the vast majority crosis to almost complete necrosis of the islets, with
only a rim of vital islet cells. Necrosis in the islets wasof cells were ED-1- and ED-2-positive macrophages.
NK cells, granulocytes, CD3+-bearing T-lymphocytes, or observed to occur almost exclusively in the center and
only occasionally in the periphery. In total 37 ± 4% ofB-cells were never observed in the histological slices.
The number of ED-1- and ED-2-positive macro- the surface of the islet was composed of necrotic cells.
Cells positively stained for apoptosis were rarely ob-phages was quantified in histological slices of free-float-
ing capsules. The total number of macrophages varied served in encapsulated islets. Apoptotic cells were ab-
sent in most grafts and present only in low and insuffi-between 10,000 and 24,000 per overgrown capsule.
From these assessments follows that with a 9.2% over- cient numbers for reliable quantification in the slices
with positively stained cells. The observation that apo-growth rate the quantity of macrophages per capsule
amounts to 1542 ± 217. ptotic cells are rarely present in encapsulated islets con-
firms our previous observations (13) that necrosis is the
Function, Replication, and Cell Death in Explanted major process responsible for islet cell death in the en-
Encapsulated Islet Grafts capsulated islets. In view of these results we focused our
subsequent in vitro studies on proliferation and necrosisAs shown in Figure 2, the explanted microencapsu-
lated islets always responded to glucose stimulation. only and abandoned quantification of apoptosis in mi-
croencapsulated islets.However, the magnitude of the response was reduced
(p < 0.05) when compared with freshly encapsulated is-
The Effect of Rat Macrophages on Function,lets. Also, we found, as in our previous study on explan-
Replication, and Cell Death in Encapsulatedted encapsulated islets (13), an incomplete return to
Islets In Vitrobasal insulin secretion (p < 0.05) during the second in-
cubation in low glucose. We questioned whether the reduced insulin responses,
the hyperproliferation, and the high number of necroticIn islets collected by peritoneal lavage we specifi-
cally determined the percentage of replicating β-cells. cells in the implanted encapsulated islets are caused by
Figure 2. Ex vivo glucose-induced insulin response of Lewis rat islets at 4 weeks after implanta-
tion (right panel) and of freshly encapsulated, control islets (left panel). Values represent mean ±
SEM of five experiments.
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tion rate of β-cells. This effect on proliferation of islet
cells was even more noticeable in co-incubations of en-
capsulated islets and LPS-activated macrophages, be-
cause β-cells in capsules had completely lost their abil-
ity to replicate.
In the absence of macrophages, encapsulated islets
were composed of 13 ± 1.3% (n = 5) of necrotic cells.
This necrosis varied from single-cell necrosis to almost
complete necrosis of the center of the islets. Necrosis
was observed to occur mainly centrally and only occa-
sionally peripherally. The severity of necrosis was not
associated with the presence of macrophages in the vi-
cinity of the capsules because the mean percentage of
necrosis was similar if not identical in encapsulated is-
lets cultured with macrophages or with LPS-activated
macrophages. Also, the severity of necrosis was not in-
creased by the presence of the capsule because naked,
nonencapsulated islets showed 11 ± 3.2% of necrotic
cells (n = 5) in the islets, a percentage similar to the per-
centage of necrosis in encapsulated islets.
DISCUSSION
It is generally assumed that the loss of islets associ-
ated with overgrowth of 2–10% of the encapsulated is-Figure 3. The percentage of replicating β-cells in islets in the
lets has no consequences for the function of the remain-normal pancreas and in microencapsulated islets at 4 weeks
ing 90–98% nonovergrown part of the graft. In theafter implantation. Values represent mean ± SEM of five ex-
periments. present study we closely mimicked the in vivo situation
to evaluate the validity of this assumption. We show that
macrophages on the 2–10% of overgrown capsules can
influence the functional survival of the graft not only bybioactive molecules secreted by the macrophages on the
9.2 ± 0.3% of overgrown capsules. To answer this ques- overgrowth and subsequent necrosis of the islets but also
by release of deleterious bioactive molecules that diffusetion we designed a coculture system with 1500 macro-
phages per islet-containing capsule (i.e., the mean num- into the 90–98% of nonovergrown capsules. These mac-
rophage-derived molecules interfere with the efficacy ofber of macrophages per capsule, vide supra), to mimic
the in vivo situation. the transplanted islets, as illustrated by our observation
that islets co-incubated with macrophages show a dis-As shown in Figure 4, co-incubation with macro-
phages had a clear-cut effect on the glucose-induced in- turbed insulin respond to a glucose load.
The observation that explanted encapsulated isletssulin response of encapsulated islets. We observed a
pronounced reduction of the basal insulin secretion (p < show an incomplete return to basal insulin secretion
after glucose challenge confirms our previous study on0.05) and the glucose-stimulated insulin secretion (p <
0.02) when compared with controls. Also, we observed function of encapsulated islets (13). A similar profile of
incomplete return to basal insulin secretion after glucosean incomplete return to basal insulin levels after glucose
challenge. This effect of macrophages on insulin secre- challenge was observed in our present in vitro study
when encapsulated islets were cocultured with macro-tion was even more pronounced in co-incubations of en-
capsulated islets with LPS-activated macrophages, be- phages. This suggests that macrophage-derived bioac-
tive factors are responsible for the observed incompletecause islets in capsules had completely lost their ability
to respond to a glucose load when LPS-activated macro- return to basal insulin levels.
Our observation that necrosis and not apoptosis ofphages were in their direct vicinity.
Co-incubation of encapsulated islets with macro- islet cells is the main cause of cell death and failure of
the graft corroborates previous findings (13). The necro-phages did not bring about a hyperproliferation of the
encapsulated islets cells (Fig. 3) as observed in explan- sis was mainly located in the central part of the encapsu-
lated islets, which suggests that insufficient nutrition isted encapsulated islets but rather a sharp decrease in the
proliferation rates (Fig. 5). Co-incubation of islets with the major cause of graft failure. This necrosis was more
severe in encapsulated islets retrieved from the perito-macrophages caused a threefold decrease in the replica-
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Figure 4. Insulin response after glucose challenge of encapsulated islets after 48 h of culture, of
encapsulated islets cocultured with macrophages for 48 h, and of encapsulated islets cocultured
with LPS-stimulated macrophages for 48 h. Values represent mean ± SEM of seven experiments.
neal cavity than in those harvested in vitro. Plausibly,
this is caused by the less favorite in vivo situation in
which factors such as oxygen tension are lower than in
vitro (11). A new and surprising observation is that the
necrosis was not influenced by the presence of a capsule
around the islets because the quantity of necrotic cells
was similar in free and encapsulated cultured islets. Ob-
viously, the capsule as such does not interfere with dif-
fusion of essential nutrients into the islets. The necrosis
is therefore caused by too slow diffusion of nutrients
through the outer cells layers of the islets.
Our present data on hyperproliferation of islet cells
confirms previous observations that encapsulated islet
cells show an extreme increase in proliferation rate after
transplantation (13). The hyperproliferation of islet cells
in vivo warrants some further consideration, because the
hyperproliferation should not be interpreted as insuffi-
cient to compensate for the increased cell death but
rather as a detrimental factor in itself. At least two
mechanisms may be involved, basically by interfering
with the islet composition. Because nonendocrine islet
cells like fibroblasts have high replication rates, the non-
endocrine cell mass will grow faster than the β-cell
mass. This occurs predominantly in the capsule periph-
ery, because there the concentration of nutrients is high-
est. The nutrition in the core of the capsule becomes
increasingly insufficient, with ischemia of β-cells and
Figure 5. The percentage of replicating β-cells in islets in en-
subsequent necrosis as a consequence. We have ob-capsulated islets after 48 h of culture, of encapsulated islets
served cell death to be restricted to the β-cells but cellcocultured with macrophages for 48 h, and of encapsulated
renewal to occur in all types of islet cells (13). Thisislets cocultured with LPS-stimulated macrophages for 48 h.
Values represent mean ± SEM of seven experiments. disturbs the normal ratio of insulin-producing and non-
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eration of cells containing cytoplasmic mu-chains, termi-insulin-producing endocrine cells, a disturbance known
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